Hexarelin: Research Profile, Dosages & Supplier Prices
Hexarelin is a growth hormone secretagogue compound with a molecular weight of 887.0 g/mol and a research half-life of approximately 30-70 minutes in published research. Hexarelin (examorelin) is a hexapeptide growth hormone secretagogue and the most potent GH releaser in the GHRP class in published comparative research. It has human clinical study history in GH deficiency diagnostics.
Research Use Only (RUO). Not for human or veterinary use. Not medical advice.
| Sequence | His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| Formula | C47H58N12O6 |
| Mol. weight | 887.0 g/mol |
| Half-life | Approximately 30-70 minutes in published research |
| Forms sold | Lyophilized vial |
What is Hexarelin?
Beyond GH research, published studies have investigated hexarelin for cardioprotective effects via CD36 receptor binding - a mechanism distinct from its ghrelin receptor activity.
Note for researchers: published studies document receptor desensitization with sustained hexarelin exposure, which is a key experimental design consideration.
Mechanism of Action (Research Context)
Ghrelin receptor (GHS-R1a) agonist with additional studied activity at CD36 receptors in cardiac tissue models.
Research Areas
Hexarelin Dosages in Research
Published human research used microgram-range single administrations. Laboratory research use only.
Dosage information is a summary of published laboratory research and is provided for informational purposes only. These compounds are not for human use.
Storage & Handling
Lyophilized: -20C. Reconstituted: 2-8C, use within 30 days.
Hexarelin Supplier Price Comparison
No tracked suppliers stock Hexarelin yet — inventory syncs run continuously. Check our supplier reviews.